ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,410 | -90.7% | 27,969 | -84.9% | 0.00% | -100.0% |
Q1 2023 | $294,056 | -64.1% | 184,941 | +40.6% | 0.00% | -66.7% |
Q4 2022 | $819,469 | +111.2% | 131,536 | +127.3% | 0.00% | +50.0% |
Q3 2022 | $388,000 | +26.8% | 57,862 | +20.4% | 0.00% | 0.0% |
Q2 2022 | $306,000 | -15.5% | 48,065 | -33.6% | 0.00% | +100.0% |
Q4 2021 | $362,000 | -58.6% | 72,352 | -0.2% | 0.00% | -66.7% |
Q3 2021 | $874,000 | +5.3% | 72,499 | +84.8% | 0.00% | 0.0% |
Q2 2021 | $830,000 | +51.5% | 39,236 | +100.7% | 0.00% | 0.0% |
Q1 2021 | $548,000 | +39.4% | 19,545 | +29.4% | 0.00% | 0.0% |
Q4 2020 | $393,000 | -76.0% | 15,109 | -45.0% | 0.00% | -70.0% |
Q4 2019 | $1,639,000 | +51.6% | 27,480 | -6.8% | 0.01% | 0.0% |
Q3 2019 | $1,081,000 | +13.9% | 29,492 | +44.6% | 0.01% | +11.1% |
Q2 2019 | $949,000 | -34.4% | 20,400 | -43.4% | 0.01% | -40.0% |
Q1 2019 | $1,447,000 | +83.2% | 36,043 | +109.8% | 0.02% | +66.7% |
Q4 2018 | $790,000 | -38.2% | 17,182 | -40.4% | 0.01% | -40.0% |
Q3 2018 | $1,278,000 | -23.7% | 28,808 | -32.6% | 0.02% | -31.8% |
Q2 2018 | $1,675,000 | +22.6% | 42,748 | +126.3% | 0.02% | 0.0% |
Q1 2018 | $1,366,000 | +100.9% | 18,886 | +82.9% | 0.02% | +83.3% |
Q4 2017 | $680,000 | +146.4% | 10,325 | +31.9% | 0.01% | +50.0% |
Q1 2017 | $276,000 | +109.1% | 7,826 | -26.0% | 0.01% | +60.0% |
Q4 2016 | $132,000 | -81.2% | 10,577 | -74.6% | 0.01% | -90.7% |
Q1 2016 | $703,000 | +71.9% | 41,600 | +732.0% | 0.05% | -59.4% |
Q2 2015 | $409,000 | – | 5,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |